City of London Group to acquire equity release firm Milton Homes

Josh White Sharecast | 11 Aug, 2017 16:27 | | |

cash money sterling pound

City Of London Group

87.50

17:18 17/10/17
-2.78%
-2.50
  • 10,802.85
  • -1.50%-163.97
  • Max: 10,966.82
  • Min: 10,802.85
  • Volume: 0
  • MM 200 : n/a
17:19 17/10/17
  • 1,032.41
  • 0.24%2.46
  • Max: 1,034.12
  • Min: 1,028.05
  • Volume: 0
  • MM 200 : n/a
17:20 17/10/17

City of London Group announced on Friday that it has conditionally agreed the acquisition of Milton Homes, and a proposed £11m equity fundraising.

The AIM-traded company proposed to acquire the entire issued share capital of Milton Homes - a provider of equity release products for residential property - for consideration of £20.2m.

That consideration was “approximately equal” to net tangible assets, and the vendor would be DV4 - a fund advised by specialist real estate investment advisory company Delancey.

COLG said the consideration for the acquisition will comprise £13.2m in new ordinary shares in in itself, and £7m in cash.

The company also proposed to raise £11m through an equity fundraising, comprising £7m through non-preemptive subscriptions and £4m through a fully underwritten open offer, both at a price of 90p per share/

MBIL agreed to subscribe for £5.8m in new ordinary shares, the board said, and to underwrite the open offer in full in respect of any entitlements not taken up.

In addition, unconnected investors reportedly agreed to subscribe for £1.2m in new ordinary shares, and Peel Hunt may also subscribe in lieu of part of MBIL's subscription to ensure that a free float of 10% is achieved following completion of the acquisition.

“The board believes that the acquisition of Milton Homes presents the company and its shareholders with an attractive opportunity to acquire a business in the equity release sector,” said COLG chairman Paul Milner.

“Building on the potential that exists within CAML, Milton Homes will enable the group to develop a broad-based financing business and moreover the additional balance sheet strength will give access to a wider range of funding lines.

“We have in place a strong and experienced board and senior management team ideally placed to drive investor value.”

Following completion of the acquisition, the subscriptions and the open offer, DV4 and MBIL would hold 51% and up to 39% respectively of the enlarged issued ordinary share capital of COLG, assuming no take-up by other shareholders in the open offer.

The company said it was proposing to change its status from an investing company for the purposes of the AIM Rules to a trading company.

It also proposed to amend its articles of association and to reorganise its share capital, to allow the subscriptions and open offer to proceed and to consolidate its ordinary shares on a 20-for-1 basis.

The acquisition would constitute a reverse takeover under AIM Rules, and as such it remained conditional on the approval of the company's shareholders in a general meeting.

In accordance with the AIM Rules, the ordinary shares in the company were suspended from trading with effect from 07300 BST, until an admission document is published in connection with the proposals.

“This acquisition is very positive for all of the parties,” said Milton Homes chairman Colin Wagman.

“Milton Homes now has the opportunity to advance its business prospects with access to a wider pool of capital and to provide it with more profile to enable it to expand its equity release products.”

Wagman said that following the transaction, existing shareholders would retain a “substantial involvement” in the future of the business.

“We are delighted that DV4 will continue as the majority shareholder.”

More news

17 Oct US close: Markets finish higher amid busy earnings season

US markets finished in the green on Tuesday, with the Dow closing just short of the 23,000 mark which it breached for the first time ever earlier in the session, amid a busy third quarter earnings season on Wall Street.

17 Oct Europe close: Stocks slip ahead of US Fed Beige Book

Stocks on the Continent finished slightly lower as investors bid their time ahead of the release of the US central bank's Beige Book on Wednesday, against the backdrop of fresh intra-day records on Wall Street's main benchmarks with the Dow Industrials having climbed above the 23,000 point mark for the first time ever.

17 Oct Buy Spain as political risk is 'overstated' - Credit Suisse

Spanish equities look unusually cheap, said Credit Suisse on Tuesday, as political risk is "overstated" and the country is on track for at least 3% growth, with employment, housing and construction all on a growth tear.

17 Oct London close: Stocks move lower even as Sterling slips

London stocks closed lower on Tuesday even as the pound fell back against the dollar, albeit following a brief pop higher after data showed inflation surged to a five-year high last month, amid somewhat dovish remarks from Bank of England policymakers.

17 Oct Director dealings: Beazley executive director sells after profit warning

Adrian Cox, executive director of risk insurance and reinsurance group Beazley, sold 180,009 shares in the company on Tuesday at the price of 500p per share.

17 Oct Credit Suisse cuts Tate and Lyle's target price, reiterates 'neutral' rating

Ahead of Tate & Lyle's interim results on 2 November, Credit Suisse updated its forecasts and cut its target price to 710p while reiterating its 'neutral' rating.

17 Oct US open: Dow Industrials clambers atop 23,000 mark for first time

The Dow Industrials climbed past the 23,000 points mark for the first time ever, as the third-quarter earnings season got into full swing, and then slipped lower.

17 Oct Higher inflation means benefits pain for households, says IFS

State benefits for roughly 10m UK families will be reduced by £450 a year in real terms after inflation reached its highest level in five years on Tuesday, the Institute for Fiscal Studies calculated.

17 Oct FTSE 250 movers: Virgin Money gains on update, Workspace boosted by JPM note

London's FTSE 250 was down 0.4% to 20,140.65 in afternoon trade on Tuesday.

17 Oct Johnson and Johnson raises full year targets after strong third quarter

Healthcare giant Johnson and Johnson posted higher than expected profits for the three months to 30 September thanks to increased demand for its new cancer drugs and the additional revenue afforded to the group from its June acquisition of Swiss biotech company Actelion.